United Kingdom · Question · Written question
UIN 3663
Cannabis: Medical Treatments
Introduced
15 January 2020
Last action
24 January 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
24 January 2020
Summary
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency has assessed the (a) safety and (b) quality of unlicensed cannabis-based products for medicinal use.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 January 2020
Written question
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency has assessed the (a) safety and (b) quality of unlicensed cannabis-based products for medicinal use.
Source: Commons
24 January 2020
Answer
Unlicensed cannabis-based products for medicinal use (CBPM) may only be imported to meet the special clinical need of individual patients. It is not currently possible to import bulk quantities of these products. This restriction forms part of the checks ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-01-15/3663
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1171028
- uk · wq-1171028 · source updated 24 January 2020